CPL Contract Development and Manufacturing of Non-Sterile Liquid and Semi-Solid Products

CDMO of non-sterile liquid and semi-solid pharmaceutical products

CPL is a contract developer and manufacturer (CDMO) of non-sterile liquid and semi-solid pharmaceutical products.

The company is uniquely focused on the development, manufacturing, packaging, and testing of creams, ointments, gels, lotions, and non-sterile solutions, as well as suspensions and nasal sprays.

With a strong record of regulatory compliance, exceptional customer service, and product expertise, CPL is the trusted choice for your pharmaceutical outsourcing projects. By offering turnkey services, from development to commercial production, CPL creates strategic relationships with customers that result in long-term successes.

The company has been in business for more than 23 years and has grown to become one of the leading contract development and manufacture organisations (CDMO) for non-sterile liquid and semi-solid products for large, mid-size, and specialty branded and generic pharmaceutical customers in North America, Europe, and Asia Pacific.

Topical semi-solid and non-sterile liquid formulation and product development

CPL’s team understands the unique challenges of developing liquid and semi-solid pharmaceutical products. Its product development services (PDS) team of 22 dedicated experts has a combined 90 years of formulation experience, with 75 years of analytical experience and has worked on a full spectrum of products.

The company’s services include development of new formulations, process optimisation, analytical method development, clinical trial supplies manufacturing, and commercial scale-up. Its team has developed many new drug application (NDA), abbreviated new drug application (ANDA), 505(b)2, and over-the-counter (OTC) products within these dosage forms. CPL has state-of-the-art pre-formulation, formulation, and analytical testing equipment, as well as labs located in its manufacturing facility including a pilot manufacturing suite for scale-up and clinical trial material projects.

Commercial manufacturing and packaging services

CPL’s good manufacturing practice (GMP) commercial operations are focused on the manufacturing and packaging of non-sterile liquid (suspensions, solutions, and nasal sprays) and semi-solid (gels, lotions, creams, and ointments) pharmaceutical products. A dedicated technology transfer team supports the company’s customers with new product launches or the transfers of existing products into our commercial manufacturing operation.

CPL has a wide variety of mixing vessels and tanks, from 20kg pilot scale to 5,000kg commercial scale, which support a variety of product types, viscosities, and processes. Its packaging capabilities include metal and laminate tubes, plastic and glass bottles, as well as jars (including metered dose pumps), nasal spray devices, and foil sachets. CPL’s offerings also include secondary packaging into unit cartons, labelling, and shrink-wrapping.

Analytical R&D, pharma product stability and testing services

As a full-service CDMO, CPL has a GMP analytical testing lab that supports product development and commercial manufacturing operations. Its GMP analytical lab provides research and development (R&D) services such as method development, cleaning validation, method transfers, and special studies.

The company conducts all routine product testing such as raw materials, bulk, and finished products, as well as microbiological testing in its internal micro lab. This lab is equipped with a large number of walk-in and portable stability chambers with ICH and custom conditions that are remotely monitored and connected to back-up generators.

Speciality pharmaceutical products manufacturing

Our manufacturing suite segregation and engineering controls allow for the handling and processing of many specialized products including high-alcohol containing or flammable materials, light or oxygen sensitivity, some potent compounds, corticosteroids and hormones. Our packaging lines support the filling of these products through use of nitrogen blanketing or dedicated areas for explosion-proof filling.

FDA and Health Canada registered facilities

CPL has two facilities, a manufacturing site in Mississauga and its testing lab in Markham, Ontario. Both sites are registered with the US Food and Drug Administration (FDA) and Health Canada and have been routinely audited by these agencies. CPL’s facilities self-identify as generic manufacturing and testing sites under the US GDUFA law and are in current standing as such.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

CPL to Exhibit at CPhI North America

CPL has announced it will be showcasing its products at CPhI North America.

White Papers

Quantitative Determination of Multiple Ingredients in Topical Formulation by Gas Chromatography

Gas chromatography (GC) is a typical chromatographic method used to separate and quantitatively determine analytes that can be volatised without decomposition.

Address
CPL (Contract Pharmaceuticals, Ltd)

7600 Danbro Crescent

Mississauga

L5N 6L6

Ontario

Canada

David Tyler: +1 716 683 3740 +1 905 821 7600 x 265 www.cplltd.com

CPL Images

Products and Services

Video

Press Release

19 January 2017

CPL has announced it will be showcasing its products at CPhI North America.

Read more
18 June 2015

Contract Pharmaceuticals Limited Canada will expand its contract manufacturing capabilities and generate business growth in the life sciences sector, with the aid of up to $8,992,672 by a member of parliament for Mississauga, Streetsville Brad Butt, on behalf of FedDev Ontario minister Gary Goodyear.

Read more
24 October 2014

Contract Pharmaceuticals Limited (CPL) will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition at the San Diego Convention Center in San Diego.

Read more

Regional Offices

CPL (Contract Pharmaceuticals, Ltd)

7600 Danbro Crescent

Mississauga

L5N 6L6

Ontario

Canada

For new business inquiries in Eastern US and Canada, please contact David Tyler Jan Sahai, Vice-President of Business Development David Tyler: +1 716 683 3740 +1 905 821 7600 x 265 www.cplltd.com

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.